700 related articles for article (PubMed ID: 7540658)
1. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
2. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
3. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
Karpus WJ; Kennedy KJ; Smith WS; Miller SD
J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
[TBL] [Abstract][Full Text] [Related]
7. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
Bebo BF; Vandenbark AA; Offner H
J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
9. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
11. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H
J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903
[TBL] [Abstract][Full Text] [Related]
13. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
Tuohy VK; Thomas DM
J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
[TBL] [Abstract][Full Text] [Related]
15. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
16. Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.
Miller SD; Tan LJ; Kennedy MK; Dal Canto MC
Ann N Y Acad Sci; 1991 Dec; 636():79-94. PubMed ID: 1724364
[TBL] [Abstract][Full Text] [Related]
17. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
18. Functional activation of myelin-specific T cells by virus-induced molecular mimicry.
Olson JK; Eagar TN; Miller SD
J Immunol; 2002 Sep; 169(5):2719-26. PubMed ID: 12193746
[TBL] [Abstract][Full Text] [Related]
19. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
[TBL] [Abstract][Full Text] [Related]
20. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD
Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
